Evidence map›Paper›PMID 29187850›Full record

ArticleFrontiers in immunology2017

Effect of Roux-en-Y Bariatric Surgery on Lipoproteins, Insulin Resistance, and Systemic and Vascular Inflammation in Obesity and Diabetes.

Rahul Yadav, Salam Hama, Yifen Liu, Tarza Siahmansur, Jonathan Schofield, Akheel A Syed, Michael France, Philip Pemberton, Safwaan Adam, Jan Hoong Ho and 9 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02169518 (Changes in Paraoxonase Activity, HDL Properties, Inflammatory Markers and Corneal Innervation in Post-bariatric Surgery Patients, Type 1 Diabetics With and Without Nephropathy, Type 2 Diabetics, and During an Oral Glucose Tolerance Test.), which is not on this map. Cited by 35 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 4 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02169518 recruitingnot on this map

Changes in Paraoxonase Activity, HDL Properties, Inflammatory Markers and Corneal Innervation in Post-bariatric Surgery Patients, Type 1 Diabetics With and Without Nephropathy, Type 2 Diabetics, and During an Oral Glucose Tolerance Test.

TypeobservationalSponsorManchester University NHS Foundation TrustRan2012 to 2030Enrolled600ConditionsDiabetes Mellitus, Bariatric Surgery Candidate
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 4 syntheses or guidelines pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 2 countries.

Rahul YadavCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Salam HamaCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Yifen LiuCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Tarza SiahmansurCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Jonathan SchofieldCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Akheel A SyedDepartment of Endocrinology and Diabetes, Salford Royal NHS Foundation Trust, Salford, United Kingdom.
Michael FranceDepartment of Biochemistry, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Philip PembertonDepartment of Biochemistry, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.
Safwaan AdamCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Jan Hoong HoCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Reza AghamohammadzadehCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Shaishav DhageCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Rachelle DonnThe Division of Musculoskeletal and Dermatological Sciences, The University of Manchester, Manchester, United Kingdom.
Rayaz A MalikCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
John P NewDepartment of Endocrinology and Diabetes, Salford Royal NHS Foundation Trust, Salford, United Kingdom.
Maria JeziorskaFaculty of Biology, Medicine and Health, The University of Manchester, Manchester, United Kingdom.
Paul DurringtonCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
Basil A AmmoriDepartment of Surgery, Salford Royal NHS Foundation Trust, Salford, United Kingdom.
Handrean SoranCardiovascular Research Group, Core Technologies Facility, The University of Manchester, Manchester, United Kingdom.
University of Manchester · GBSalford Royal NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeObesity is a major modifiable risk factor for cardiovascular disease. Bariatric surgery is considered to be the most effective treatment option for weight reduction in obese patients with and without type 2 diabetes (T2DM).

objectiveTo evaluate changes in lipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction following Roux-en-Y bariatric surgery in obese patients with and without diabetes. MATERIALS AND

methodsLipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction were measured in 37 obese patients with (

resultsThere was a significant effect of

conclusionLipoproteins, insulin resistance, mediators of systemic and vascular inflammation, and endothelial dysfunction improve mostly 6 months after bariatric surgery in obese patients with and without diabetes. CLINICAL

trial registrationwww.ClinicalTrials.gov, identifier: NCT02169518. https://clinicaltrials.gov/ct2/show/NCT02169518?term=paraoxonase&cntry1=EU%3AGB&rank=1.

Indexed as

diabetesinsulin resistancelipoproteinsRoux-en-Yvascular inflammation

Identifiers

PMID29187850
PMCPMC5694757
OpenAlexW2770340333

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.